A cross-sectional study in Addis Ababa found HIV viral non-suppression reached 11.3% among pregnant and lactating women receiving antiretroviral therapy. Investigators evaluated suppression status in a cohort of 496 women and quantified how often viral control failed during routine treatment. The report adds to ongoing adherence and coverage discussions by focusing on a high-contact population—pregnant and lactating patients—where program designs must support sustained suppression. The findings point to the need for targeted interventions to address gaps in viral control even within ART-managed care.